273
Views
0
CrossRef citations to date
0
Altmetric
Abstracts

Author Index

Pages 173-180 | Published online: 18 Oct 2010

Abdelnour-Mallet M, 135

Abel O, 118

Abraham I, 25

Abrahams S, 32, 148, 162

Abrescia C, 117

Acevedo-Arozena A, 20

Adachi H, 83

Aebischer P, 52

Ahn S-W, 69

Ahtoniemi T, 70, 91

Aiso S, 22

Aizawa H, 108

Ajroud-Driss S, 111, 139

Akimoto C, 110

Alami N, 10

Al-Chalabi A, 29, 118, 154

Ali-Rahmani F, 79

Allcroft P, 17

Allen C, 21

Allen J, 139

Al-Nakhala B, 83

Al-Sarraj S, 104

Alvarez JL, 100

Alvisi E, 105, 115

Andersen PM, 29, 30, 49, 104, 106, 110, 112, 118

Andersson R, 110

Andjus P, 103

Ando H, 139, 140

Andres P, 23

Angus R, 139, 140

Ansorge O, 31, 99

Aoun S, 17

Appel S, 137

Archibald D, 36, 65, 141

Armes S, 169

Armon C, 120

Armstrong III E, 90, 117

Armstrong J, 139

Arnulf I, 126

Arts I, 23

Asayama S, 99

Atassi N, 49

Atkin J, 37, 89, 93, 99, 101

Avants B, 146

Ayala V, 54

Azzouz M, 169

Backus C, 71

Bahrke R, 41, 156

Bak TH, 32

Baker M, 114

Ball L, 153

Balma M, 17, 28, 56, 156

Banfi P, 129

Banno H, 83

Barbarini N, 106

Barber R, 171

Bareil C, 20

Barnham K, 68, 69

Barohn R, 154

Barrett E, 55

Barrett J, 55

Basta I, 155

Bastin M, 162

Bates S, 104

Battaglia G, 26, 169

Bäumer D, 31

Beart PM, 92

Bede P, 1, 131, 148, 157, 162

Bedlack R, 44

Beelen A, 127

Beghi E, 27

Bella P, 50

Belzil V, 114

Benatar M, 49

Bendotti C, 97

Benfenati F, 73

Bennett FC, 9

Berger J, 74, 75

Berman B, 43

Berna C, 147

Bernabei C, 121

Bersano E, 17, 144

Berwick J, 169

Bettinelli M, 50

Bhargava N, 38

Bianchi M, 105

Biba A, 31

Bica L, 68

Bigi R, 105

Bini L, 100

Birbaumer N, 24

Birve A, 110

Bizovicar N, 165

Black KJ, 18, 127, 128, 150, 151

Blair I, 116

Blasco H, 126

Blass B, 85

Blauw H, 29, 30

Blizzard CA, 87, 94

Blok J, 24

Blythe A, 150, 151

Boada J, 54

Bockenek WL, 128, 151

Boekestein W, 23

Boggio BD, 135

Boiocchi C, 115

Bokde A, 162

Bon J, 2, 164

Bonanno G, 73

Bonetto V, 97

Bongioanni P, 100, 117

Bonifacino T, 73

Bonino D, 117

Borisow N, 41, 156, 157

Bosco D, 30, 53

Bottacchi E, 28

Bouchard J-P, 114

Bowser R, 25, 102, 105

Boylan K, 33, 114, 119, 137

Bozik M, 36, 65, 141

Bradley D, 115

Brady S, 84

Brännström T, 104, 106

Bravver E, 18, 128, 150, 151, 152

Bremer B, 50

Brocard C, 39

Bromberg M, 56

Brooks BR, 18, 57, 80, 85, 90, 91, 117, 119, 128, 132, 140, 141, 150, 151, 152

Brothers A, 14, 146, 49

Brown RH Jr, 29, 30, 53, 107, 116

Brown R, 80

Brownlee A, 13

Brownstein C, 154

Bruening L, 13

Bruneteau G, 108, 135

Bucci EM, 117

Burke C, 53

Busta A, 21

Cacabelos D, 54

Caioli S, 94

Callagher P, 129

Calvo A, 17, 28, 56, 81, 135, 144, 156, 168

Cammarosano S, 17, 156

Campos Y, 100

Campous D, 103

Camu W, 114, 145

Canosa A, 17, 28, 144, 156

Canu N, 94

Caraballo-Miralles V, 54

Caragounis A, 90

Carrasco MA, 9

Carrion I, 82, 168

Carunchio I, 94

Casey P, 139

Cashman JR, 98

Cashman N, 52, 107

Cassel J, 85

Castelnuovo G, 129

Cazzolli P, 140, 141, 57

Cellotto N, 129, 50

Cereda C, 105, 106, 115, 98

Ceroni M, 105, 106, 115, 98

Cha J, 66

Chakrabarti B, 139, 140

Chalbi M, 135

Champion S, 101

Chan M, 65

Chang G, 88

Chatburn R, 57, 140

Chaverri D, 151

Chaves CA, 133

Chen G, 85

Chen H, 77

Chen R, 66

Chen X, 76

Chiang P, 167, 78

Chiheb D, 15

Chiò A, 17, 28, 56, 135, 144, 156

Chuah MI, 67

Chun S, 105

Chung R, 67

Clavelou P, 135

Clawson L, 138

Cleary S, 58

Cleveland DW, 9, 46

Cleveland M, 104

Coates J, 171

Coccia C, 92

Cohen SR, 12

Cohen-Fineburg I, 129

Coleman MP, 37

Collins M, 102

Colombrita C, 112

Colyer S, 17

Conceição E, 63, 133

Condon S, 120

Conforti L, 37

Connor J, 22, 54, 79, 109

Consoli P, 117

Conte A, 111, 153

Conway T, 78

Cooper L, 93

Corbo D, 161

Corbo M, 50, 97, 126, 129

Corcia P, 126

Corse A, 104

Cova E, 98, 105, 106, 115

Cox G, 74

Crawford J, 116

Creemers H, 127

Crook R, 114

Crouch P, 68, 69, 90

Cuccia M, 115

Cudkowicz M, 23, 36, 44, 49, 65, 105, 124, 141

Cui L, 76

Culvenor J, 68

Cunha M, 133

Cuppen E, 30

Currow D, 17

D’Ydewalle C, 15

Da Costa M, 21

Dahlberg C, 30

Dahodwala N, 136

Daoud H, 114

Das M, 38, 86

David G, 55

Davin A, 98

Davis H, 86

De Carvalho M, 1, 138, 166

De Jong SW, 27, 123, 124

De Visser M, 27, 30, 123, 124

Dedic V, 155, 158

Deitch J, 82

Dejesus-Hernandez M, 114

Del Grande A, 111, 153

Delanian S, 157

Deng M, 33, 85, 88

Dengler R, 132, 167

Desai U, 150, 151, 152

Desaro P, 114

Desjarlais A, 114

Desnuelle C, 135

Dewhurst E-K, 134

Dhand U, 171

Dhillon H, 68, 83

Di Maio G, 100

Di Stefano A, 100

Dick A, 154

Dickson D, 107

Dickson TC, 87, 94

Diekmann V, 24

Diekstra F, 30

Diez TE, 123

Dimachkie M, 154

Dion P, 114

Doi H, 83

Dolenc GL, 120

Donaghy C, 160

Donkervoort S, 111

Donnelly P, 68, 69

Doretti A, 112

Douaud G, 163

Dowling J, 21

Drenthen J, 24

Dreo J, 164

Drew A, 116

Droce A, 79

Drory V, 82

Duan W, 87, 88, 89

Dubourg O, 108

Duce J, 68

Duffy KS, 128, 151

Dullinger JS, 41, 156, 157

Dupré N, 114

Duran M, 133

Durand J, 39, 170

Durham H, 66, 93

Durnall J, 116

Duyckaerts C, 108

Ealing J, 143

Ebers G, 125

Edis R, 17

Edwards G, 171

Eggan K, 97

Elamin M, 148, 162

Elbasiouny S, 170

Elman L, 136, 146

Elmo M, 59, 136

Endo H, 110

England JD, 7

Ensrud E, 154

Ermans E, 74

Esposito F, 161

Esteban J, 100

Fadda M, 135

Fagan A, 162

Fajardo ML , 130

Fan D, 33, 85, 88 109, 165, 167

Fang D-F, 111, 164

Fanos J, 49

Farace E, 14

Farg M, 37, 89, 93, 101

Fathinia P, 159

Federico A, 100

Feldman E, 21, 71

Felgoise S, 18, 50, 126

Fernandes F, 81

Fernández E, 100

Ferraiuolo L, 46

Filipchuk A, 39

Filippini N, 25, 163

Filiz G, 90

Finch N, 114

Finocchiaro E, 135

Fischetti C, 120

Fisher EMC, 20

Fisher F, 144, 147

Flaherty-Craig C, 146

Fling B, 160

Focant M, 75

Forbes R, 160

Forsberg K, 104

Forshew DA, 7, 34, 101

Fossati F, 129

Foster S, 67

Fratta P, 20

Friedman BA, 9, 10

Frosali S, 100

Fu R, 38, 72, 169

Fujita K, 99

Fukuda M, 133

Fukumaki Y, 113

Fumoto K, 30, 84

Furlong CE, 30

Gagliardi A, 100

Gagliardi S, 98, 115

Gal J, 53

Galletti R, 135

Gallo S, 17, 28, 144, 156

Gamez J, 63, 113

Gandhi RB, 152

Ganesalingam J, 25

Ganzini L, 12

García A, 100

García-Chacón L, 55

García-Redondo A, 168

Gastl R, 159

Gdynia H-J, 159

Gellera C, 30, 116

Gély-Nargeot M-C, 145

Georgoulopoulou E, 121

Geser F, 107

Ghiroldi A, 106

Giacone S, 156

Gibbons C, 143

Gibson MJ, 160

Gill A, 68, 70, 83

Gilley J, 37

Giniatullin R, 70

Giniatullina R, 70

Giribaldi F, 73

Gitler AD, 52

Glass JD, 30, 116

Golaszewski A, 136

Goldoni CA, 121

Goldsteins G, 91

Gonzalez M, 86

Gordon P, 135

Gorelik R, 132

Gorni K, 129

Goursaud S, 74, 75

Grad L, 107, 52

Graff-Radford N, 114

Granado A, 54

Graves M, 119

Green M J, 14

Greenald D, 46

Greensmith L, 20

Gribkoff V, 36, 65, 141

Grissom J, 78

Groen E, 30, 84

Gronka S, 49

Grossman M, 146

Gruis K, 42, 160

Grupstra H, 127

Guareschi S, 98, 105, 106

Gueritaud JP, 39

Gullusci M, 117

Gunawardena D, 146

Guo X, 86

Guo X-Y, 111, 164

Guo Y, 73, 77, 87, 88, 89

Guy N, 135

Hadano S, 75, 96

Hanson K, 9

Hardiman O, 1, 29, 115, 131, 148, 157, 160, 162

Harmar A, 80

Harris R, 17, 41

Hartley R, 80

Hayward L, 53

Hazelett D, 77

He X, 110

He Z, 103

Healey M, 56

Heath P, 46

Heckman CJ, 38, 72, 169, 170

Hefferan M, 71

Heiman-Patterson T, 82

Heizmann C, 144

Heller S, 139

Hemendinger R, 80, 90

Henderson C, 52, 97

Hensler M, 68, 131

Hermans E, 75

Hernández M, 152

Heywood J, 44

Hickey J, 68

Hickman J, 38, 86

Hicks S, 147

Hideyama T, 108

Higginbottom A, 21, 46

Hill J, 134

Hilton D, 31

Hodges JR, 145

Hodskins J, 131

Hokonohara T, 113

Holm T, 41, 156, 157

Hong Y, 71

Honrada R, 101

Horne M, 37, 89, 93, 99, 101

Horton KD, 119

Hosie KA, 87, 94

Hoskins K, 136

Houseman G, 49

Hovatter R, 160

Hu M, 77

Hu X-H, 164

Huang E, 107

Huang J, 73

Huang R, 111, 164

Huelga S, 9

Huggins J, 42

Huisman MHB, 27, 123, 124

Hurtado F, 151, 152

Hutt KR, 9

Iber C, 57, 58

Ikeda J-E, 75, 96

Ikeda K, 75, 166

Ilardi A, 17

Ingersoll E, 36, 65, 141

Irobi J, 15

Ishikawa H, 96, 98

Ishikawa Y, 166

Ito H, 29, 99

Iwaki T, 113

Iwamoto K, 166

Iwasaki Y, 75, 166

Izumi Y, 29

Jack B, 13, 130

Jackson CE, 7, 154

Jackson V, 17

Jaffa M, 49, 105

Jaffer Z, 66

Jang J-W, 69

Janzen C, 41

Jaronen M, 91

Javaherian A, 26

Jelsone-Swain L, 160

Ji Y, 33

Jia H, 53

Jia J, 53

Jia Y, 87, 88

Jiang H, 88, 89

Jiang M, 169

Jin L, 47

Johe K, 71, 86

Johnston A, 114

Johnston WS, 7, 58

Jonsson A, 110

Jordan N, 148, 162

Joyce P, 20

Julien J-P, 20

Juntas-Morales R, 145

Kaji R, 29

Kalra S, 58, 7

Kamada M, 29

Kamitani T, 95

Kanazono S, 171

Kandinov B, 82

Kaneko S, 99

Kanekura K, 22

Kanekura M, 22

Kanninen K, 70

Kanning K, 52

Kaplan A, 52

Kaplan C, 59, 136

Karlsson PR, 79

Kasarskis EJ, 7, 44, 56, 131

Kassubek J, 24, 45, 159, 163

Katirji B, 59, 136, 137

Katsuno M, 83

Katz JS, 7, 34, 35, 64, 101, 137, 154

Kawabe K, 166

Kawakami H, 29

Kaye W, 119

Keagle P, 30, 116

Keegan L, 11

Kenna K, 115

Kennard C, 147

Kennelly K, 114

Kennerley A, 169

Khan A, 147

Kidd J, 68, 70, 83

Kihira T, 122

Kikuchi H, 113

Kim JM, 11

Kim K-E, 69

Kim SH, 9

Kimball R, 138

King AE, 87, 94

Kira J-I, 113

Kirby J, 46

Kissel J, 154

Kitamura E, 155

Klapper J, 49

Kleine B, 23

Klug R, 159

Knight S, 163

Knorr R, 120

Ko Hae K, 53

Kocerha J, 114

Kocher K, 82

Koistinaho J, 70, 91

Kokubo Y, 122

Kolarcik C, 102

Kollewe K, 132, 167

Kondo N, 83

Kondo T, 122

Kong J, 76

Korczyn A, 82

Koritnik B, 120, 165

Korogod S, 39

Kostic S, 155

Kraig S, 48

Krakow M, 43

Krampfl K, 132

Krishnan J, 15

Kristjanson L, 17

Kryscio R, 56

Kubalik N, 80, 91

Kulagina I, 39

Kunita R, 96

Kusaka H, 29, 99

Kushner G, 34

Kuzmanovic A, 158

Kuzuhara S, 122

Kwak S, 108

Kwiatkowski T, 53

Kwinter D, 53

Kwon O-S, 69

Lacomis D, 25, 105

Laforenza U, 98

Lafronza A, 34

Lagier-Tourenne C, 9

Lain AH, 108

Lam L, 68

Landers JE, 29, 30, 116

Landi C, 100

Langford V, 128, 151

Lanka V, 124

Lattante S, 111

Lau CL, 92

Lauranzano E, 97

Lavrnic D, 155, 158

Le Forestier N, 135

Lechtzin N, 137, 138

Leclerc AL, 30, 116

Lecorney A, 145

Lee G, 76

Lee S, 22, 79

Lee V M-Y, 7

Lee Y, 47

LeGuern E, 108

Lei P, 75

Leigh PN, 60, 104

Lemay N, 53

Lemmens R, 30

Lenglet T, 135

Leonardis L, 120

Lepore A, 48

Levi B, 14

Lewarski J, 57, 140

Lewis K, 67

Li C, 73, 77, 87, 88, 89

Li J, 39

Li Q-X, 68, 69, 90

Li W-Y, 72

Li X, 11

Li Y, 92

Li Z, 73, 77, 87, 89

Liabeuf S, 39

Liang TY, 9

Libon D, 146

Lillo P, 145

Lim N, 68

Lim S, 68, 69

Limousin N, 126

Lincecum J, 82, 168

Lindblom SS, 151

Ling S, 9

Linke P, 41, 156, 157

Liou L, 11

Lista S, 106

Liu H-N, 76

Liu Y, 22, 73, 87, 88, 109

Lladó J, 54

Loeb J, 78, 167

Lomen-Hoerth C, 107

Lorenzl S, 68, 131

Lowe J, 31

Lu J, 88, 89

Lu S, 22

Ludolph AC, 24, 29, 30, 45, 113, 144, 159, 163

Luigetti M, 111, 153

Lulé D, 24, 144

Lunetta C, 50, 97, 126, 129

Lunn S, 71

Lyter J, 49

Ma M-Y, 111

Ma Y, 89

Maathuis E, 24

Macías AI, 151, 152

Mackay C, 163

Mackenzie I, 107

Madia F, 111, 153

Madison C, 101

Madsen J, 169

Maestri E, 50

Magga J, 70

Magni P, 106

Maier A, 41, 156, 157

Mallet J, 108

Malm T, 70

Maloteaux J-M, 74, 75

Mancino MV, 135

Mancuso I, 111

Mandl RC, 160

Mandrioli J, 121

Maniatis T, 9, 97

Manzano R, 81, 168

Maragakis N, 48, 97, 137

Marangi G, 111

Marchiaro M, 117

Marconi A, 129

Maria Joaquina D, 63

Marín S, 130, 151, 152

Marklund SL, 104, 106, 110

Marsala M, 71

Martín R, 100

Maruyama H, 29

Mascías J, 151

Masel R, 82

Massagli M, 154

Masters C, 68, 69, 90

Mather J, 36, 65

Matsuda C, 141

Matsuo Y, 95

Matsuoka M, 22

Matte G, 161

Matthews D, 56

Mazur C, 9

Mazzini L, 28, 56

McCluskey L, 136, 146

McConigley R, 17

McDermott C, 21

McDermott MP, 35

McGivern CR, 160

McGoldrick P, 20

McGurk L, 11

McGrath MS, 101

McKenna-Yasek DM, 30, 53, 116

McKim D, 57, 140

McMillan C, 146

McVey A, 154

Mead R, 169

Meininger V, 44, 104, 108, 135

Meleo E, 153

Melisa A, 144

Mendaña L, 100

Mendiondo M, 56

Menke R, 25

Meola G, 50

Merino V, 100

Messa M, 73

Messina S, 34, 112

Meyer T, 29, 41, 45113, 156, 157

Meyerowitz J, 90

Mikami H, 96, 98

Milanese M, 73

Milani P, 105, 115

Milazi S, 85

Milde S, 37

Millecamps S, 108

Miller RG, 7, 34, 35, 36, 64, 101, 137

Miller T, 105

Milosevic M, 103

Minaya FJ, 151

Minamiyama M, 83

Mioshi E, 145

Misiaszek J, 58

Mitchell JD, 13, 129, 130, 143

Mitsumoto H, 7, 56, 65, 132

Miura S, 113

Mochizuki H, 155

Moglia C, 17, 56, 144, 156

Mohammadi B, 167

Molinari E, 129

Möller T, 11

Molnar P, 86

Monsurrò MR, 161

Montagnoli L, 117

Montarrás D, 81

Monteforte M, 97

Montuschi A, 144

Moore DH, 34, 35, 36, 64

Mora G, 28, 56, 97

Mora JS, 100, 130, 151, 152

Morales M, 113

Morán Y, 130, 152

Moreira G, 142

Morelli C, 34, 112

Moreno A, 68, 70

Morino H, 29

Morita M, 110, 112

Morrison B, 92

Morton D, 77

Moser JM, 79

Mougeot J-L, 85, 117

Moy P, 82

Mozaffar T, 154

Mueller H-P, 163

Müller H-P, 24

Münch C, 41

Muñoz JM, 81, 168

Muratet M, 9

Muravov O, 119

Musazzi L, 73

Mutani R, 28

Muzyka I, 154

Myers R, 9

Nagai M, 122

Nagley P, 101

Nakamura M, 99

Nakano I, 110

Nakayama Y, 141

Nandar W, 22, 54, 79

Nardo G, 97

Natale M, 117

Naudí A, 54

Neely B, 79

Neely E, 22, 54

Nefussy B, 82

Neumann M, 113

Neuwirth C, 110, 112

Newman D, 137

Nguyen K, 55

Nichelli P, 121

Nichols MS, 18, 128, 150, 151

Nicholson G, 116

Nilsson A-C, 110

Nishii M, 99

Nizet Y, 75

Nollet F, 127

Nomura M, 96, 98

O Brannagain D, 131

O’Banion C, 48

O’Brien D, 171

O’Brien M, 13, 130

O’Connell M, 11

O’Connor M, 17

O’Neil M, 128, 151

O’Neill M, 107

O’Shea RD, 92

Ogino M, 133, 155

Ogino Y, 155

Ogura A, 141

Ohyagi Y, 113

Okamoto K, 122

Oliván S, 81, 168

Oliveira A, 1, 133, 142

Oliver D, 131

Onders R, 59, 136, 137

Ono S, 96, 98

Ono S-I, 66

Onofri F, 73

Ophoff R, 29, 30

Oplinger H, 128

Oreja GC, 123

Ortiz-Padilla C, 79

Osta R, 81, 168

Otera A, 133

Otomo A, 75, 96

Overeem S, 23

Paccico T, 151

Paccone A, 161

Pacut C, 71

Pageot N, 145

Pagnini F, 126, 129

Paine S, 31

Palovcak M, 136

Pambo-Pambo A, 39

Pamplona R, 54

Pankratz N, 57, 58

Panov A, 91

Panzeri M, 50

Papadeas S, 48

Papurello D, 17

Parish C, 89

Park K-Y, 69

Parker S, 90

Paro S, 11

Pasnoor M, 154

Pasterkamp JR, 30, 84

Patel S, 57, 58

Pattee G, 153

Patterson B, 69

Patterson V, 160

Pauli F, 9

Pavlis A, 147

Pavlovic A, 158

Pawlyk A, 85

Pellizzoni L, 15

Pender N, 148

Perren F, 112

Perrin S, 82, 168

Petri S, 132, 167

Pettit L, 162

Phaneuf D, 20

Phatak V, 20

Phatnani HP, 9

Philip S, 21

Phukan J, 148

Piccirillo G, 161

Pieri M, 94

Piggin L, 140

Pignataro M, 97

Pillen S, 23

Pinnock R, 160

Pinto A, 138

Pinto S, 138, 166

Pioro E, 161

Platt S, 171

Podnar S, 164

Poletti B, 34

Poli A, 117

Pollari E, 70

Polymenidou M, 9

Ponfick M, 159

Ponsky J, 136

Popoli M, 73

Portero-Otín M, 54

Potter C, 56

Pouget J, 135

Powell J, 118

Pozzi S, 97

Pradat P-F, 104, 108, 135, 157

Pradella-Hallinan M, 142

Praline J, 126

Preston H, 129

Price A, 117, 85

Price K, 90

Puchalski R, 168

Qi X, 76

Quadros A, 1, 142

Queen E, 78

Quinlan K, 38

Rabe M, 113

Rabinowitz R, 82

Rademakers R, 114

Raju TR, 172

Ramesh T, 21

Ratti A, 112, 30

Ravina B, 35

Ravits J, 11

Raykar V, 134

Reardon K, 147

Reddy T, 9

Reed W, 83

Reiter-Theil S, 12

Reitz A, 85

Repovš G, 164

Ribchester R, 80

Ringer C, 81

Ristic KS, 120

Rivetti M, 135

Robberecht W, 15, 29, 30

Robertson J, 10, 76

Rodellar C, 81

Rodriguez de Rivera FJ, 123

Rodriguez-Leyva I, 30

Rosenberg A, 21

Rosenfeld J, 7, 42, 154

Rossi B, 100

Rossi G, 129

Rothstein J, 47, 92, 97, 104, 137

Rouleau G, 114

Roy-Bellina S, 145

Rubinstein A, 66

Rudnicki S, 141

Rumsey J, 38, 86

Rush B, 33

Russo P, 151, 152

Rutherford N, 114

Rutkove S, 39

Sabatelli M, 111, 153

Sabet D, 135

Sagnelli A, 161

Sakashita E, 110

Sakowski S, 21

Salachas F, 108, 135

Salas T, 130, 152

Saling S, 43

Sanchez M, 119

Sanchez R, 82, 168

Sanelli T, 10

Sanjak MS, 128, 151, 152

Sansone V, 50

Sanz Gallego I, 123

Sapp PC, 30, 53, 116

Sarma T, 84

Sasaki S, 104

Sawada J, 108

Schelhaas HJ, 23, 27, 30, 123, 124

Schengrund C-L, 79

Schilz R, 59, 136

Schmalbach S, 132

Schmalix W, 68

Schmitt-John T, 79

Schoenfeld D, 36

Schuster J, 38, 72, 169

Schütz B, 81

Scotto M, 138

Seidler R, 160

Seilhean D, 108

Sellitti L, 56

Sepulveda L, 119

Shang H-F, 76, 111, 164

Shapiro B, 107

Sharma R, 147

Sharp P, 169

Shaw CA, 76

Shaw CE, 25

Shaw G, 25

Shaw P, 46, 143, 169

Sheean R, 92

Shefner J, 36, 44

Sher R, 74

Sherman A, 65, 124

Sherratt N, 68

Sheward J, 80

Shimizu T, 141

Shin H-W, 69

Shoesmith C, 7

Siddique N, 111, 49

Siddique T, 38, 111, 139, 169

Sieniawski M, 132

Silani V, 30, 34, 112, 116

Silva T, 63, 133, 142

Simmons Z, 14, 18, 22, 49, 50, 54, 56, 79, 109, 126, 146

Simpson E, 137

Sinani E, 65

Singleton E, 42

Sinzenich T, 167

Skerry L, 23

Slowik A, 29

Smith R, 10

So Y, 137

Sobue G, 83

Sola P, 121

Solca F, 34

Solski J, 116

Song F, 78, 167

Song X, 88

Soo K Y, 89, 93, 101

Soon C, 68, 69, 90

Sorg S, 144

Soriani M-H, 135

Soundarararjan P, 74

Spano G, 97

Sperfeld A-D, 159, 163

Spiller K, 52

Spitalny M, 34

St. Clair W, 131

Stancescu M, 38, 86

Stanislaw C, 49

Stephens HE, 18, 50

Stevic Z, 103, 155, 158

Stewart J, 77

Stipa G, 111

Stojanovic Rakocevic V, 155

St-Onge J, 114

Strober J, 107

Strong MJ, 7, 103

Strulovici B, 26

Stukovnik V, 120, 164

Stutzki R, 12

Sufit R, 139

Sutedja N, 123, 124

Suzuki H, 22

Suzuki K, 83

Suzuki M, 96, 98

Svoboda R, 146

Swarup V, 20

Swash M, 125, 138, 166

Syriani E, 113

Takahashi K, 133

Talbot K, 25, 31, 99, 143, 147, 154, 163

Tan J-L, 68

Tanaka F, 83

Tandan R, 56

Tardito D, 73

Taroni F, 30

Tateishi T, 113

Taverna R, 144

Taylor B, 43

Taylor E, 134

Taylor PJ, 10

Tedeschi G, 161

Tennant A, 143

Thoeng A, 116

Thomas V, 116

Thompson K, 68, 70, 83

Thomson D, 80

Thornton C, 15

Thornton E, 139, 140, 143

Tibbetts R, 9

Ticozzi N, 30, 34, 112, 116

Tierbach J, 112

Tiloca C, 112

Timmerman V, 15

Tiryaki E, 57, 58

Toivonen J, 81

Tokuda E, 66

Tomik B, 29

Tonali PA, 111, 153

Toronjo M, 154

Torre-Merino P, 168

Torri V, 97

Towne C, 52

Tradewell M, 66, 93

Trojanowski J, 107

Trojsi F, 161

Tsingalia A, 92

Tufik S, 142

Turner B, 37, 68, 89, 93, 99

Turner M, 25, 31, 125, 147, 154, 163

Uckingham M, 81

Umbertina R, 63

Unrath A, 163

Urano F, 22

Usuki S, 95

Valan M, 34

Valera HF, 151, 152

Van Blitterswijk M, 30

Van Damme P, 15, 30

Van Den Berg LH, 27, 29, 30, 84, 123, 124, 127, 160

Van Den Berghe P, 15

Van Den Bosch L, 15

Van Den Heuvel MP, 160

Van Der Hulst E-J, 32

Van Der Kooi AJ, 27, 30, 123, 124

Van Doormaal PTC, 27

Van Doorn P, 24

Van Es M, 29, 30

Van Vught P, 29, 30

Vasquez L, 171

Veldink JH, 27, 29, 30, 123, 124, 127, 160

Verschueren A, 135

Verstraete E, 160

Vickers JC, 87, 94

Vieira F, 68, 70, 83, 168

Villamil AJ, 171

Vinci E, 117

Visser G, 24

Waibel S, 29, 113

Walgren K, 128, 151

Walker A, 37, 89, 93, 101

Walker M, 49

Wallace K, 124

Walsh S, 18, 49, 50

Wan Q, 109

Wancewicz E, 9

Wang J, 85, 88

Wang K, 33

Wang L, 39, 169

Wang M, 82, 168

Wang Q, 73, 77

Wang Y-H, 72, 154

Ward AL, 128, 132, 151

Warraich S, 116

Watanabe T, 96, 98

Weber M, 12, 110, 112

Wei L, 33

Weihe E, 81

Weinreich S, 27

Wells S, 56

Welsh R, 160

West A, 67

Wheeler S, 58

White A, 68, 69, 90

Whitehead B, 13, 130

Wicks P, 44, 154

Wiener C, 138

Williams C, 140

Williams K, 116

Williams NM, 18, 127, 128, 150, 151

Wills A-M, 30

Winer L, 105

Wojtas A, 114

Wolfe L, 139

Woolley SC, 7, 33, 34

Wren P, 42

Wright KA, 128, 150, 151

Wszolek Z, 114

Wurster U, 167

Wurthner J, 104

Wuu J, 49

Xiao S, 10

Xie Y-M, 72

Xu Y, 110, 165

Yamano T, 96, 98

Yamashita T, 108

Yanai A, 52

Yang Y, 111, 47

Yao X, 110

Yap YC, 87

Yasui K, 96, 98

Yates P, 17

Yeo GW, 9

Yoshida S, 122

Yoshii Y, 75, 166

Youn Y-C, 69

Young C, 139, 140, 143

Young J, 18

Yu H, 65

Yu J, 87

Yu RK, 95

Yu X, 88, 89

Zaragoza P, 81, 168

Zeng Y, 111, 164

Zetterström P, 106

Zgonc V, 120

Zhai J, 53

Zhang B, 78

Zhang C, 72

Zhang J, 53, 107, 165

Zhang K, 73, 77

Zhang R, 101

Zhang S, 165

Zhang Y, 85, 88, 167

Zhao B, 111

Zhao C-P, 72

Zhao X-S, 154

Zheng J, 165

Zheng M, 109

Zhou C, 72

Zhou D, 111

Zhou H, 53

Zhu H, 53

Zidar I, 120, 165

Zidar J, 120, 164, 165

Zinkie S, 66

Zinman L, 10

Zollino M, 111

Zona C, 94

Zwarts M, 23

Zwiegers P, 76

Subject Index

AAC, 13

AAC-compliance, 42

access, 41

activities of daily living, 133

activity, 80, 83

acylated steryl glucoside, 95

adaptive equipment, 132

ADAR2, 108

adherence, 139

adult motoneuron, 38

advanced care planning, 14, 129

advocacy, 44

aggregates, 93

airway clearance, 58

alcohol, 124

ALDH1L1, 47

alexithymia, 145

alpha-synuclein, 95

algorithm, 168

ALS team communication, 128

ALS2, 96

ALSFRS-R, 35, 36, 50, 65

ALS-PDC, 76, 95

altered mental status, 128

alternative splicing, 77

amino acids, 98

AMPA receptor, 108

androgen receptor, 83

angiogenin, 30, 110

angiogenin P (-4)Q, 110

angiogenin V105A, 110

animal model, 172

anosognosia, 146

antibodies, 107

antisense oligonucleotides, 105

apathy, 144, 145

apoptosis, 100

assessment, 12, 50

assistive

devices, 133

technology, 42, 132

association, 30

astrocytes, 46, 73, 75, 92

astroglia, 47, 97

Ataxin-2, 52

attitudes, 136

audit, 127

autolysosome, 104

automation, 83

autonomic impairment, 82

autophagosome, 96, 104

autophagy, 11, 69, 104

axon

degeneration, 87

pathology, 94

axonal transport, 37

basophilic inclusions, 31, 113

behaviour, 144

behavioural changes, 145

bioinformatics, 117, 118

biology, 60

biomarker, 25, 163, 167, 168

bionanotechnology, 26

BMI, 155

brain, 91

bulbar, 153

bulbar

involvement, 165

onset, 153

bursts, 169

Ca2+ homeostasis, 103

calcium, 93, 122

candidate, 115

canine, 171

caregiver

assessment, 49

needs, 49

caregivers, 129

care-giving, 50, 144

carer burden, 145

carer, 12

case

control, 17

management, 128

caspase, 75

cell

autonomy, 48

biology, 77

death mechanisms, 90

cellular therapy, 63

cerebrospinal fluid, 25, 102, 106, 172

CGRP, 81

Charcot-Marie-Tooth disease, 15

cholecystitis, 155

cholesterol, 79

classification, 148

clinical

assessment, 151, 152

evaluation, 153

progression, 64

trial, 36, 44, 64, 65, 124, 138

  conduct, 44

  design, 35, 64

CLIP, 10

CMAP scan, 24

CNV, 29

cognition, 34, 144, 147, 162, 164

cognitive, 147, 148, 162

cognitive

change, 32

functioning, 144

impairment, 33, 146

screen, 33

cognitive/behaviour

impairment, 148

communication device, 132

communication, 13

co-morbid conditions, 124

compliance, 44

computer-based decision aid, 14

computerized tools, 34

consensus criteria, 148

copy number, 82

corpus callosum, 163

cortical neurons, 94

cortical thickness, 160

cross-cultural comparison, 126

CSF, 105

CuII(atsm), 68

culture model, 66

culture, 81

cycloergometer, 50

cytokines, 115

data management, 65

database, 118, 119, 120

de novo, 114

death certification, 121

decision-making, 136

deep vein thrombosis, 156

default-mode network (DMN), 161

degeneration, 7, 80

degenerative myelopathy, 171

delivery system, 26

depression, 143, 144

development, 39

dexpramipexole, 36, 65

diagnosis, 23, 166

diagnosis/prognosis, 97

diagnostic

journey, 13

validity, 33

diaphragm function, 59

diaphragm pacing, 59, 136, 137

diffusion tensor imaging (DTI), 24, 25, 160, 163

dimebolin, 68

disease

mechanisms, 93

progression, 23, 120, 161

specific certification, 151

disulfide bond 76

dosimetry, 157

Drosophila, 11, 77, 78

duplex sonography, 156

dying back, 37

dynein, 37

dysarthria, 153

dysfunction, 162

dyspnea, 141

early phase, 33

EDC, 65

education, 17

efficacy data for NIV, 139

EGCG, 87

electromyography, 164, 165, 166

electrophysiology, 38, 94, 170

eliminating rate, 167

embodied cognition, 32

embryonic stem cells, 74, 85

emergency

hospitalizations, 57

services, 134

end of life care, 12, 17

end-of-life, 13, 14, 129

energy expenditure, 56

enrichment, 85

enrolment, 44

ensheathing cells, 63

epidemiology, 27, 120, 121, 122

ER stress, 22, 37, 89, 93, 101

ER-Golgi, 37

estrogens, 123

euthanasia, 12

evaluation, 17

event related potentials, 164

evolution, 123

excitability, 72

excitotoxicity, 44, 54, 87, 88, 94, 103, 170

executive function, 146

exercise, 145

exocytosis, 73

exome sequencing, 116

exon array, 77

extracellular matrix, 102

eye-tracking, 147

falls, 134

familial ALS, 49, 111

family carers, 130

fast axonal transport, 84

fatigue, 142, 143

fcMRI, 160

ferritin, 166

financial cost, 130

fluoxetine, 72

flutamide, 84

fMRI, 24

frontal functions, 34

frontotemporal, 147

frontotemporal

dementia, 49, 162

lobar degeneration, 146

functional

status, 143

tests, 165

FUS/TLS, 9, 31, 53, 84, 107, 108, 113, 114

ganglioside antibodies, 167

gastrostomy, 136

GCLC, 73

G-CSF, 70

gender, 122

gene, 116

gene

expression, 77

identification, 116

networks, 117

profiling, 52

genetics, 30, 112, 113

genetic

background, 74

counselling, 49

testing, 49

genome wide study, 118

genome-wide association study, 29

GFAP, 75

glia, 9, 48, 94

glial

activation, 78

cells, 104

cytoplasmic inclusion, 113

glucose, 100

glutamate, 75, 92

glutamate

excitotoxicity, 87

injury, 109

release, 73

transporter 1, 74

GSEA, 117

GSK-3 inhibitor, 69

guidelines, 7

handedness, 154

hazard ratio predictive value, 138

HFE, 22, 79, 109

HFE

gene, 110

H63D, 54

high-resolution EEG, 164

high-throughput

screen, 85

sequencing, 9

Hirayama disease, 157, 164

historical controls, 64

history, 125

HO-1, 88, 89

Hodgkin, 157

home

care, 128

parenteral nutrition, 135

hospice care, 140

hSOD1G93A, 74, 88

Hsp90 inhibitor, 66

human mesenchymal stem cells, 72

human, 86

hydrotherapy, 133

hyperlipidemia, 155

hyper-metabolism, 100

hypoventilation, 58

IGF-I, 71

IgG, 103

imaging, 162

immobilisation, 156

immunohistochemistry, 81

immunomodulation, 70

impairment-quantification, 151, 152

impedance, 39

in vitro, 38, 86

incidence, 27, 28, 121, 122

incident, 148

inclusion body myositis, 108

indirect calorimetry, 135

inflammation, 70

inflammation/activation

markers, 101

inherited ALS, 49

in-home services, 128

injury, 134

insight, 146

internet web patient portal, 18

interneurons, 169

interstitial space, 106

interventions, 50

intramuscular injection, 67

intronic mutation, 110

iPSC, 26, 97

iron, 54, 109

ISH, 168

juvenile ALS, 31

key worker, 41

Kii-ALS, 122

lactate stress test, 167

language, 32

laser capture microdissection, 11

lateral corticospinal tract, 167

lifestyle factors, 122

linear mixed effects model, 35

linkage, 116

lipid rafts, 79

lipids, 166

longitudinal, 34

longitudinal study, 129

lower extremity amyotrophic diplegia, 154

LST-decisions, 144

lymphocytes, 100

macrophage, 82

malnutrition, 135

mass spectrometry, 25, 102

mechanical ventilation, 155

mechanism of action, 69

medical emergency, 134

metabolism, 47, 92

metallothionein, 66, 67

metals, 90

methodology, 148

microarray, 46, 78, 117

microRNA, 11

misfolded SOD1, 106

mitochondria, 55, 80, 93

mitochondrial

abnormalities, 104

apoptosis, 101

respiratory chain, 100

transmembrane potential

  (MTP), 100

modeling, 39, 170

modifier, 74

monitoring, 166

monocyte/macrophage

activation, 101

monomelic amyotrophy, 157

morphology, 39

mortality, 121

motor

acquisition, 63

behaviour, 172

cortex, 160

nerve terminal, 55

neuron biology, 11

neuron degeneration, 79

neurons, 9, 46, 85, 87, 97

mouse models, 15, 20

movement related cortical potential, 165

MRI, 157, 162, 164, 169

mRNA, 98

multidisciplinary care, 18, 134

MUNE, 39, 171

muscle, 81

muscle

atrophy, 168

biopsy, 168

pathology, 104

mutation, 20, 30, 107, 111, 114

myofibrillary architecture, 104

nanoparticles, 169

national databases, 119

natural voice, 42

needs assessment, 127

neuregulin, 78, 167

neurodegeneration, 78, 80

neurofilament, 103

neuroimaging, 161

neurology clinical trials unit, 65

neuromuscular junction (NMJ), 38, 80, 86, 87

neuronal viability, 22

neurons, 7, 26

neuropathology, 102, 125

neurophysiology, 24

neuroprotection, 21

neuropsychological

assessment, 34

neuropsychology, 32

neurotransmitters, 171

next-generation sequencing, 116

NFkB, 29

nicotinamide, 85

NIPPV, 137

NIV, 56, 57, 137, 138, 139, 140, 141

NIV titration, 57

noncompliance, 139

noninvasive positive pressure ventilation, 140

non-neuronal cell, 66

Nrf2, 88, 89

NSC-34 cells, 84, 90

nuclear localization sequence (NLS), 53

nucleus, 104, 105

nursing

care, 43

role for NIV, 139

nutrition, 56

occupational therapy, 133

ocular fixation, 160

oculomotor, 52

oligodendroglia, 47

‘omics’, 60

onset, 154

optical imaging, 169

optineurin, 29

oral secretions scale, 141

oral secretions, 140

orthopnea, 141

outcome, 28, 56

outcome

measures, 23, 150, 152

registry, 119

out of hours, 134

outpatient care, 41

oxidation, 76, 106

oxidative damage, 54

oxidative stress, 21, 88, 90, 105

p.R521C, 113

pain, 17

palliative

care, 17, 41, 131

care education, 17

paraoxonase, 30

parkinsonism-dementia

complex (PDC), 96

parotid, 131

pathoanatomy, 163

pathology, 82, 107

pathway, 115

patient

management, 7

outcomes, 151

PEG, 136

percutaneous endoscopic gastrostomy tube, 136

performance measures, 150, 151

peripheral

blood mononuclear cells, 97

neuropathy, 15

permeability transition pore, 55

personal experiences, 13

pharmaceuticals, 26

pharmacology, 92

phase II trial, 35

phenotype, 20, 28, 60, 112, 153, 161, 167

phosphorylated

Smad2/3, 99

TDP-43, 54

phrenic

nerve, 137

nerve motor response, 138

physical activity, 50, 123

physician/patient communication, 17

pilot projects, 119

pioneers, 125

PMA, 154

polymorphisms, 115

polysomnography, 57, 58

population-based study, 56

population-based, 17, 27, 123, 124

postnatal development, 38

post-polio syndrome, 142

practice parameters, 7

predictive equations, 56

Preferred Priorities for Care, 129

prefrontal

dysfunction, 32

lobar dysfunction, 33

prevalence, 120, 121, 124

primary endpoint, 35

primitive reflexes, 147

prion-like activity, 52

prognosis, 25, 153

progression, 24, 167

prospective memory, 33

protein

aggregation, 102

biomarkers, 97

disulfide isomerase, 91

misfolding, 52, 93, 107

-protein interaction, 84

proteomics, 10

PSP, 160

psychological assessment, 126

PTEN, 109

qualitative

analysis, 143

research, 13, 130

quality improvement, 128

quality of life, 12, 18, 126, 128, 129, 132, 143

quantitative

sensory testing, 159

strength measures, 23

Rab5, 96

radiation, 131

radiologic inserted

gastrostomy, 135

radiotherapy, 157

rapamycin, 69, 70, 94

rare variant, 29

rare variation, 30

rat, 39

reactive astrocyte, 47

recruitment, 44

redistribution, 89

registry, 119, 120

rehabilitation, 42, 58

relationships, 43

reliability, 141

religiosity, 12

remote evaluations, 49

research question, 35

resistance, 52

respiration, 58, 165

respiratory failure, 57, 59, 137

resting

energy expenditure, 135

state, 160

resting-state functional

magnetic resonance imaging (RS-fMRI), 160, 161

restless legs syndrome, 126

resveratrol, 85, 88

retention, 44

riluzole, 88

risk factors, 27

risk, 123

RNA, 10, 103

RNA

binding proteins, 52

editing, 11

metabolism, 10

processing, 9

splicing, 15

transcriptiome, 47

root recording, 169

ROS, 91

saccades, 160

safety, 135

sample size, 35

satellite cells, 81

SBMA, 83, 84

Schwann cells, 82

screening, 34

SELDI-TOF-MS, 106

self-management, 41

sensory system, 24

sequencing, 115

serotonin, 72

sexual expression, 43

sexuality, 43

sialorrhea, 131

single nucleotide polymorphism, 110

Sirt1, 85

sit to stand test, 152

skin, 96

sleep disturbance, 126

sleep, 57, 142

SMA, 15, 99

SMA type I, 63

Smad ubiquitination

regulatory factor-2, 99

small-fibre neuropathy, 159

smoking, 124

social

cognition, 32

problem solving skills, 18

social-care, 130

SOD1, 20, 21, 52, 75, 78, 80, 82, 91, 98, 101, 104, 105, 106, 107, 110, 111

SOD1

aggregation, 76

conformation, 76

G93A mouse, 67, 68, 70

mouse, 38

mutation, 111

transgenic mice, 82

-G93A, 68, 70, 83, 168

-G93A mice, 67, 68, 70, 72, 73

-G93A/HFE+/H67D, 54

I113T, 111

software, 119, 131

somatosensory nerve system, 159

Spain, 130

speech therapy, 132

spinal

cord, 98

cord heart mitochondria, 91

spirituality, 12

splice

variant, 110

variants, 74

sporadic ALS, 99

spread, 154

stair climbing test, 152

STARD, 23

stem cells, 48, 63, 71

stigmasterol β-D-glucoside, 76

stress

granules, 53

response, 66

structural MRI, 146

study biological markers, 45

substantia nigra, 158, 159

suicide, 12

sulforaphane, 88

support, 130

survey, 42

survival motor neuron, 15, 99

survival, 120, 155

swallowing, 58

Switzerland, 112

sympathetic activity, 82

symptom control, 131

symptomatic

management, 131

therapy, 159

synthetic technology, 26

Talampanel, 44

TAR DNA, 85

TARDBP gene, 111

TARDBP, 112, 113

TARDP mutations, 112

TDP-43, 7, 9 10, 20, 52, 68, 77, 85, 89, 90, 108, 109, 112

technology, 43

telemedicine, 49

tele-nursing, 18

telephone advice, 18

terminal illness, 12

TGF-beta, 83, 99

The Joint Commission, 150

therapeutic, 69, 71

therapy, 64, 68

Tie-2, 101

timed-tests, 151, 152

transcranial sonography, 159

transcranial, 158

transcription factor, 69

transgenic mice, 66, 73

transplantation, 72

transporters, 75, 92

transthyretin, 102

trapezius, 165

treatment acceptability, 140

ubiquitination, 117

ultrasonography, 23, 158

ultrastructural studies, 96

unfolded protein response, 22

university palliative care unit, 131

uPA inhibitor WX-340, 68

uPA, 68

urate, 166

valproic acid, 63

VAPB, 22

VEGF inhibitor, 156

ventilation, 138

vesicle traffic, 79

vital capacity, 141

voice-banking, 42

voxel-based morphometry, 161

VSC4.1 cell line, 88

vulnerability, 81

walk, 133

Wallerian degeneration, 37

web-based self-assessment, 41

wobbler mouse model, 79

zebrafish, 21, 53

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.